Clinical Trial Finder | Pancreatic Cancer Action Network

Back to Trial Search

Phase I Study of Palbociclib in Combination With Cisplatin or Carboplatin in Advanced Solid Malignancies

Summary

The purpose of this phase I trial is to study the side effects and best dose of palbociclib with cisplatin or carboplatin in treating patients with solid tumors that have spread to other places and usually cannot be cured or controlled with treatment.

General Information

NCT#: NCT02897375
Study ID: IRB00089583
Trial Phase: Phase I

Trial Sponsor: Pfizer, Emory University
Therapies Used in This Trial: Cisplatin, Carboplatin, Palbociclib

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account? Sign In

Request an Account

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account.
In order to view this information, you need to be signed in as a Health Care Provider.
In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
This information is restricted to validated Health Care Providers.

Eligibility

-------------------------------------------------------------------------------------------

In order to view this information, you need to be signed in as a Health Care Provider.
You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
------------------------------------------------------------------------------------------------------
In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information

Back to Trial Search